Effects of Dimeric PSD-95 Inhibition on Excitotoxic Cell Death and Outcome After Controlled Cortical Impact in Rats

Area of Science:

• Neuroscience
• Pharmacology
• Trauma Research

Background:

• Postsynaptic density-95 (PSD-95) inhibition shows therapeutic potential in stroke models.
• Traumatic brain injury (TBI) shares some pathological mechanisms with stroke, suggesting PSD-95 inhibition could be beneficial for TBI.

Purpose of the Study:

• To evaluate the efficacy of a novel dimeric PSD-95 inhibitor, UCCB01-144, against excitotoxic cell death in vitro.
• To assess the therapeutic effects of UCCB01-144 on outcomes following experimental TBI in rats.
• To determine the pharmacokinetic profile of UCCB01-144, including its central nervous system penetration.

Main Methods:

• Neuronal cultures were used to test UCCB01-144 against NMDA-induced excitotoxicity.
• Adult rats underwent controlled cortical impact TBI and received immediate intravenous injections of saline or UCCB01-144 (10 or 20 mg/kg).
• Cognitive function (spatial learning and memory) was evaluated using a water maze, and lesion volumes were measured post-mortem.

Main Results:

• UCCB01-144 did not provide protection against NMDA-induced excitotoxicity in neuronal cultures.
• Administration of UCCB01-144 did not improve spatial learning and memory or reduce lesion volume in rats subjected to TBI.
• Pharmacokinetic analysis results were not explicitly detailed but were intended to assess CNS uptake.

Conclusions:

• The dimeric PSD-95 inhibitor UCCB01-144 demonstrated no therapeutic benefit in preclinical models of TBI or excitotoxicity.
• Further investigation is required to identify critical factors influencing the efficacy of PSD-95 inhibitors in TBI treatment.